{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:02:31Z","timestamp":1781625751486,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1124\/molpharm.120.000131","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T23:40:14Z","timestamp":1601077214000},"page":"648-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8973-4569","authenticated-orcid":false,"given":"Mateusz P.","family":"Czub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore J.","family":"Rastelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil R.","family":"Tasker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taber S.","family":"Maskrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella K.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley E.","family":"McQueeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Bushweller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-7090","authenticated-orcid":false,"given":"Wladek","family":"Minor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wipf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Sharlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-4025","authenticated-orcid":false,"given":"John S.","family":"Lazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.120.000131_bib1","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1158\/0008-5472.CAN-15-2323","article-title":"Novel anticancer agents based on targeting the trimer interface of the PRL phosphatase","volume":"76","author":"Bai","year":"2016","journal-title":"Cancer Res"},{"key":"10.1124\/molpharm.120.000131_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/15216540400016286","article-title":"Binding of anti-HIV drugs to human serum albumin","volume":"56","author":"Bocedi","year":"2004","journal-title":"IUBMB Life"},{"key":"10.1124\/molpharm.120.000131_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/molpharm.120.000131_bib4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/1869","article-title":"Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites","volume":"5","author":"Curry","year":"1998","journal-title":"Nat Struct Biol"},{"key":"10.1124\/molpharm.120.000131_bib5","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1021\/acs.jmedchem.0c00225","article-title":"Albumin-based transport of nonsteroidal anti-inflammatory drugs in mammalian blood plasma","volume":"63","author":"Czub","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/molpharm.120.000131_bib6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/0008-5472.CAN-07-2349","article-title":"A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage","volume":"68","author":"Daouti","year":"2008","journal-title":"Cancer Res"},{"key":"10.1124\/molpharm.120.000131_bib7","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1158\/0008-5472.CAN-14-0673","article-title":"Phosphatase PTP4A3 promotes triple-negative breast cancer growth and predicts poor patient survival","volume":"76","author":"den Hollander","year":"2016","journal-title":"Cancer Res"},{"key":"10.1124\/molpharm.120.000131_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/molpharm.120.000131_bib9","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.str.2017.10.009","article-title":"Validation of structures in the protein data bank","volume":"25","author":"Gore","year":"2017","journal-title":"Structure"},{"key":"10.1124\/molpharm.120.000131_bib10","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1107\/S2059798316014716","article-title":"A public database of macromolecular diffraction experiments","volume":"72","author":"Grabowski","year":"2016","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1124\/molpharm.120.000131_bib11","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1073\/pnas.1815361116","article-title":"Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism","volume":"116","author":"Hardy","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.120.000131_bib12","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.18632\/oncotarget.23186","article-title":"Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance","volume":"9","author":"Hjort","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/molpharm.120.000131_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40164-018-0100-2","article-title":"Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration","volume":"7","author":"Hjort","year":"2018","journal-title":"Exp Hematol Oncol"},{"key":"10.1124\/molpharm.120.000131_bib14","doi-asserted-by":"crossref","first-page":"W351","DOI":"10.1093\/nar\/gkw357","article-title":"Dali server update","volume":"44","author":"Holm","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.120.000131_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/molpharm.120.000131_bib16","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1107\/S1399004714024572","article-title":"ACHESYM: an algorithm and server for standardized placement of macromolecular models in the unit cell","volume":"70","author":"Kowiel","year":"2014","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/molpharm.120.000131_bib17","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: a new approach","volume":"64","author":"Kratochwil","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/molpharm.120.000131_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40591-016-0048-8","article-title":"Albumin-based drug delivery: harnessing nature to cure disease","volume":"4","author":"Larsen","year":"2016","journal-title":"Mol Cell Ther"},{"key":"10.1124\/molpharm.120.000131_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.119.262188","article-title":"Next-generation cell-active inhibitors of the undrugged oncogenic PTP4A3 phosphatase","volume":"371","author":"Lazo","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.120.000131_bib20","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1096\/fj.201701446R","article-title":"A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion","volume":"32","author":"McQueeney","year":"2018","journal-title":"FASEB J"},{"key":"10.1124\/molpharm.120.000131_bib21","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.18632\/oncotarget.23787","article-title":"Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor","volume":"9","author":"McQueeney","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/molpharm.120.000131_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fphys.2014.00299","article-title":"Unraveling the mysteries of serum albumin-more than just a serum protein","volume":"5","author":"Merlot","year":"2014","journal-title":"Front Physiol"},{"key":"10.1124\/molpharm.120.000131_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/mol.119.118927","article-title":"New author guidelines for displaying data and reporting data analysis and statistical methods in experimental biology","volume":"97","author":"Michel","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.120.000131_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1107\/S0907444906019949","article-title":"HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes","volume":"62","author":"Minor","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/molpharm.120.000131_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/molpharm.120.000131_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1124\/molpharm.120.000131_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol"},{"key":"10.1124\/molpharm.120.000131_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1107\/S0907444906005270","article-title":"Optimal description of a protein structure in terms of multiple groups undergoing TLS motion","volume":"62","author":"Painter","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/molpharm.120.000131_bib29","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.7150\/thno.34883","article-title":"Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"},{"key":"10.1124\/molpharm.120.000131_bib30","series-title":"All About Albumin: Biochemistry, Genetics, and Medical Applications","author":"Peters","year":"1995"},{"key":"10.1124\/molpharm.120.000131_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1107\/S2059798315024730","article-title":"Fitmunk: improving protein structures by accurate, automatic modeling of side-chain conformations","volume":"72","author":"Porebski","year":"2016","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1124\/molpharm.120.000131_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation: physiological, pharmacokinetic and clinical implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/molpharm.120.000131_bib33","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1039\/C6OB00946H","article-title":"Photooxygenation of an amino-thienopyridone yields a more potent PTP4A3 inhibitor","volume":"14","author":"Salamoun","year":"2016","journal-title":"Org Biomol Chem"},{"key":"10.1124\/molpharm.120.000131_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/0889311X.2018.1521805","article-title":"Refining the macromolecular model - achieving the best agreement with the data from X-ray diffraction experiment","volume":"24","author":"Shabalin","year":"2018","journal-title":"Crystallogr Rev"},{"key":"10.1124\/molpharm.120.000131_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jmb.2006.06.028","article-title":"Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis","volume":"361","author":"Simard","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1124\/molpharm.120.000131_bib36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17425247.2015.993313","article-title":"Albumin and its application in drug delivery","volume":"12","author":"Sleep","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1124\/molpharm.120.000131_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134336","article-title":"Procyanidins negatively affect the activity of the phosphatases of regenerating liver","volume":"10","author":"Stadlbauer","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.120.000131_bib38","first-page":"1052","article-title":"Further characterization of specific drug binding sites on human serum albumin","volume":"12","author":"Sudlow","year":"1976","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.120.000131_bib39","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1039\/C9OB00025A","article-title":"In-flow photooxygenation of aminothienopyridinones generates iminopyridinedione PTP4A3 phosphatase inhibitors","volume":"17","author":"Tasker","year":"2019","journal-title":"Org Biomol Chem"},{"key":"10.1124\/molpharm.120.000131_bib40","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bmcl.2019.06.048","article-title":"Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors","volume":"29","author":"Tasker","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/molpharm.120.000131_bib41","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1038\/s41467-019-10127-x","article-title":"PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein","volume":"10","author":"Thura","year":"2019","journal-title":"Nat Commun"},{"key":"10.1124\/molpharm.120.000131_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1107\/S0907444909042589","article-title":"Molecular replacement with MOLREP","volume":"66","author":"Vagin","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/molpharm.120.000131_bib43","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1016\/j.bbagen.2013.06.032","article-title":"Structural studies of several clinically important oncology drugs in complex with human serum albumin","volume":"1830","author":"Wang","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/molpharm.120.000131_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41389-020-0192-5","article-title":"Protein tyrosine phosphatase 4A3 (PTP4A3\/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo","volume":"9","author":"Wei","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1124\/molpharm.120.000131_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1124\/molpharm.120.000131_bib46","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1021\/acs.chemrev.7b00105","article-title":"Regulatory mechanisms and novel therapeutic targeting strategies for protein tyrosine phosphatases","volume":"118","author":"Yu","year":"2018","journal-title":"Chem Rev"},{"key":"10.1124\/molpharm.120.000131_bib47","first-page":"387","article-title":"Reference values for serum proteins of common laboratory rodent strains","volume":"48","author":"Zaias","year":"2009","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1124\/molpharm.120.000131_bib48","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/cbic.201800201","article-title":"Roles of albumin-binding proteins in cancer progression and biomimetic targeted drug delivery","volume":"19","author":"Zhao","year":"2018","journal-title":"ChemBioChem"},{"key":"10.1124\/molpharm.120.000131_bib49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1107\/S0907444910020421","article-title":"Validation of crystallographic models containing TLS or other descriptions of anisotropy","volume":"66","author":"Zucker","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"}],"updated-by":[{"DOI":"10.1124\/molpharm.120.000131err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2401112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2401112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.120.000131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:36:35Z","timestamp":1739961395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2401112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0026895X2401112X"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.120.000131","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/molpharm.120.000131err","asserted-by":"object"}]},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.120.000131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}